New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants
Viruses · 2023
DOI: 10.3390/v15010206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Antonio Marchini und 11 weiteren Autor:innen. Beteiligte Einrichtung: European Commission, Joint Research Centre (JRC), 2440 Geel, Belgium. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple lineages of SARS-CoV-2 have been identified featuring distinct sets of genetic changes that confer to the virus higher transmissibility and ability to evade existing immunity. The continuous evolution of SARS-CoV-2 may pose challenges for current treatment options and diagnostic tools. In this study, we have first evaluated the performance of the 14 WHO-recommended real-time reverse transcription (RT)-PCR assays currently in use for the detection of SARS-CoV-2 and found that only one assay has reduced performance against Omicron. We then developed a new duplex real-time RT-PCR assay based on the amplification of two ultra-conserved elements present within the SARS-CoV-2 genome. The new duplex assay successfully detects all of the tested SARS-CoV-2 variants of concern (including Omicron sub-lineages BA.4 and BA.5) from both clinical and wastewater samples with high sensitivity and specificity. The assay also functions as a one-step droplet digital RT-PCR assay. This new assay, in addition to clinical testing, could be adopted in surveillance programs for the routine monitoring of SARS-CoV-2’s presence in a population in wastewater samples. Positive results with our assay in conjunction with negative results from an Omicron-specific assay may provide timely indication of the emergence of a novel SARS-CoV-2 variant in a certain community and thereby aid public health interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Commission, Joint Research Centre (JRC), 2440 Geel, Belgium.
- Seidor Italy S.r.l., 20129 Milan, Italy.
- Department of Microbiology, Laboratoire National de Santé, 3583 Dudelange, Luxembourg.
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.
- Biological Resource Center of Institut Pasteur, Université Paris Cité, 75015 Paris, France.
- KWR Water Research Institute, 3433 PE Nieuwegein, The Netherlands.
ORCID-Profile: Antonio Marchini, Mauro Petrillo, Amy Parrish, Gerhard Buttinger, Philippe Corbisier
Zitieren
APA
Marchini, A., Petrillo, M., Parrish, A., Buttinger, G., Tavazzi, S., Querci, M., Betsou, F., Elsinga, G., Medema, G., Abdelrahman, T., Gawlik, B., & Corbisier, P. (2023). New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants. Viruses. https://doi.org/10.3390/v15010206
Vancouver
Marchini A, Petrillo M, Parrish A, Buttinger G, Tavazzi S, Querci M, et al. New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants. Viruses. 2023. doi:10.3390/v15010206
BibTeX
@article{Marchini2023,
author = {Marchini, Antonio and Petrillo, Mauro and Parrish, Amy and Buttinger, Gerhard and Tavazzi, Simona and Querci, Maddalena and Betsou, Fay and Elsinga, Goffe and Medema, Gertjan and Abdelrahman, Tamir and Gawlik, Bernd and Corbisier, Philippe},
title = {New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010206}
}
EUVIMED